11-6634202-G-A

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_003737.4(DCHS1):​c.1902C>T​(p.His634His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.372 in 1,613,462 control chromosomes in the GnomAD database, including 112,556 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.35 ( 9698 hom., cov: 33)
Exomes 𝑓: 0.37 ( 102858 hom. )

Consequence

DCHS1
NM_003737.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.559

Publications

22 publications found
Variant links:
Genes affected
DCHS1 (HGNC:13681): (dachsous cadherin-related 1) This gene is a member of the cadherin superfamily whose members encode calcium-dependent cell-cell adhesion molecules. The encoded protein has a signal peptide, 27 cadherin repeat domains and a unique cytoplasmic region. This particular cadherin family member is expressed in fibroblasts but not in melanocytes or keratinocytes. The cell-cell adhesion of fibroblasts is thought to be necessary for wound healing. [provided by RefSeq, Jul 2008]
DCHS1 Gene-Disease associations (from GenCC):
  • mitral valve prolapse, myxomatous 2
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • van Maldergem syndrome 1
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia
  • familial mitral valve prolapse
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • van Maldergem syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 11-6634202-G-A is Benign according to our data. Variant chr11-6634202-G-A is described in ClinVar as Benign. ClinVar VariationId is 259136.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.559 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.432 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DCHS1NM_003737.4 linkc.1902C>T p.His634His synonymous_variant Exon 3 of 21 ENST00000299441.5 NP_003728.1 Q96JQ0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DCHS1ENST00000299441.5 linkc.1902C>T p.His634His synonymous_variant Exon 3 of 21 1 NM_003737.4 ENSP00000299441.3 Q96JQ0
ENSG00000255410ENST00000526633.1 linkn.211-730G>A intron_variant Intron 2 of 2 3
ENSG00000255410ENST00000656961.1 linkn.309+2773G>A intron_variant Intron 2 of 2

Frequencies

GnomAD3 genomes
AF:
0.353
AC:
53661
AN:
151964
Hom.:
9694
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.280
Gnomad AMI
AF:
0.336
Gnomad AMR
AF:
0.367
Gnomad ASJ
AF:
0.416
Gnomad EAS
AF:
0.447
Gnomad SAS
AF:
0.339
Gnomad FIN
AF:
0.384
Gnomad MID
AF:
0.424
Gnomad NFE
AF:
0.380
Gnomad OTH
AF:
0.367
GnomAD2 exomes
AF:
0.373
AC:
93582
AN:
250790
AF XY:
0.373
show subpopulations
Gnomad AFR exome
AF:
0.276
Gnomad AMR exome
AF:
0.352
Gnomad ASJ exome
AF:
0.411
Gnomad EAS exome
AF:
0.447
Gnomad FIN exome
AF:
0.393
Gnomad NFE exome
AF:
0.385
Gnomad OTH exome
AF:
0.390
GnomAD4 exome
AF:
0.374
AC:
546697
AN:
1461378
Hom.:
102858
Cov.:
58
AF XY:
0.374
AC XY:
271614
AN XY:
726958
show subpopulations
African (AFR)
AF:
0.277
AC:
9256
AN:
33474
American (AMR)
AF:
0.352
AC:
15734
AN:
44690
Ashkenazi Jewish (ASJ)
AF:
0.408
AC:
10670
AN:
26120
East Asian (EAS)
AF:
0.461
AC:
18288
AN:
39694
South Asian (SAS)
AF:
0.328
AC:
28240
AN:
86194
European-Finnish (FIN)
AF:
0.388
AC:
20689
AN:
53384
Middle Eastern (MID)
AF:
0.394
AC:
2269
AN:
5766
European-Non Finnish (NFE)
AF:
0.377
AC:
419249
AN:
1111692
Other (OTH)
AF:
0.369
AC:
22302
AN:
60364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
20620
41241
61861
82482
103102
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13182
26364
39546
52728
65910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.353
AC:
53695
AN:
152084
Hom.:
9698
Cov.:
33
AF XY:
0.353
AC XY:
26231
AN XY:
74334
show subpopulations
African (AFR)
AF:
0.280
AC:
11606
AN:
41482
American (AMR)
AF:
0.367
AC:
5615
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.416
AC:
1441
AN:
3466
East Asian (EAS)
AF:
0.447
AC:
2310
AN:
5164
South Asian (SAS)
AF:
0.339
AC:
1634
AN:
4814
European-Finnish (FIN)
AF:
0.384
AC:
4063
AN:
10584
Middle Eastern (MID)
AF:
0.418
AC:
123
AN:
294
European-Non Finnish (NFE)
AF:
0.380
AC:
25827
AN:
67968
Other (OTH)
AF:
0.365
AC:
770
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1768
3536
5305
7073
8841
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
530
1060
1590
2120
2650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.369
Hom.:
7182
Bravo
AF:
0.347
Asia WGS
AF:
0.363
AC:
1267
AN:
3478
EpiCase
AF:
0.373
EpiControl
AF:
0.375

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 06, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Van Maldergem syndrome 1 Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.51
CADD
Benign
7.5
DANN
Benign
0.85
PhyloP100
0.56
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs997263; hg19: chr11-6655433; COSMIC: COSV55037241; API